Novo Nordisk: Novo Nordisk ties up with Metaphore to develop new obesity drugs
LONDON: Novo Nordisk signed a research tie-up with US biotech firm Metaphore on Thursday to develop next-generation obesity drugs.Why it’s Important Danish drugmaker Novo is trying to expand beyond its blockbuster obesity drug Wegovy with at least eight other treatments in its R&D pipeline for the condition. The collaboration will use Metaphore’s tech platform to … Read more
